Genenta Closes Its Upsized Initial Public Offering of American Depository Shares

by NASDAQ Market News December 17, 2021

NASDAQ Market News
Click here to email author

Zai Lab Partner argenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis

U.S. FDA Approves Supplemental New Drug Application for Expanded Indication of Oxbryta® (voxelotor) for Children as Young as 4 Years of Age with Sickle Cell Disease

Ads